About Frontage Laboratories
Frontage Laboratories is a company based in Exton (United States) founded in 2001 was acquired by Tigermed in May 2014. Frontage Laboratories has raised $10.24 million across 1 funding round from investors including Tigermed and Baird Capital. The company has 1,560 employees as of December 31, 2024. Frontage Laboratories has completed 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research and BioTranex. Frontage Laboratories offers products and services including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services. Frontage Laboratories operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine, among others.
- Headquarter Exton, United States
- Employees 1560 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Frontage Holdings Corp.
-
Annual Revenue
$256.23 M (USD)-2.23as on Dec 31, 2024
-
Net Profit
$794.44 K (USD)-92.71as on Dec 31, 2024
-
EBITDA
$45.83 M (USD)-17.68as on Dec 31, 2024
-
Total Equity Funding
$10.24 M (USD)
in 1 rounds
-
Latest Funding Round
$10.24 M (USD), Series A
Apr 25, 2008
-
Investors
Tigermed
& 1 more
-
Employee Count
1560
as on Dec 31, 2024
-
Investments & Acquisitions
Acme Bioscience
& 6 more
-
Acquired by
Tigermed
(May 08, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Frontage Laboratories
Frontage Laboratories is a publicly listed company on the HKEX with ticker symbol 1521 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Frontage Laboratories
Frontage Laboratories offers a comprehensive portfolio of products and services, including Drug Discovery Services, Drug Development Services, and Laboratory Testing Services.
Provides end-to-end chemistry and biology for drug candidates
Supports preclinical and clinical trial processes
Offers bioanalytical and analytical testing for pharmaceuticals
People of Frontage Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Frontage Laboratories
Frontage Laboratories has successfully raised a total of $10.24M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.24 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Frontage Laboratories
Frontage Laboratories has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Tigermed and Baird Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Locked | Locked | Locked | |
|
Drug development and preclinical services are provided by Tigermed.
|
Locked | Locked | Locked |
Investor details for Frontage Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Frontage Laboratories
Frontage Laboratories has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Acme Bioscience, BRI Biopharmaceutical Research and BioTranex.
Investment portfolio details for Frontage Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DMPK and analytical services are offered via hepatocyte-based platforms.
|
Locked | Locked | 2009 | Locked | |
|
ADME and DMPK services are provided through mass spectrometry techniques.
|
Locked | Locked | 2009 | Locked | |
|
Provider of a wide range of genomics services
|
Locked | Locked | 2006 | Locked |
Complete acquisition details for Frontage Laboratories
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Frontage Laboratories
Detailed financials for Frontage Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Frontage Laboratories Comparisons
Peer comparison for Frontage Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Frontage Laboratories
Frontage Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Precision for Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Frontage Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Frontage Laboratories
Complete news archive for Frontage Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Frontage Laboratories
Frontage Laboratories was founded in 2001 and raised its 1st funding round 7 years after it was founded.
Frontage Laboratories is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Frontage Laboratories is a funded company, having raised a total of $10.24M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Frontage Laboratories is 1,560.
Annual revenue of Frontage Laboratories is $256.23M as on Dec 31, 2024.
Frontage Laboratories was established in 2001 in Exton, United States, operating as a contract research organization in the pharmaceutical and biotechnology sectors. Early-phase drug development services are delivered, encompassing bioanalytical laboratory operations, discovery-stage activities, preclinical metabolism and pharmacokinetics studies, phase IIIa clinical trials, and product development support. Organic synthesis, formulation development, GMP analytical testing, and clinical trial material manufacturing under GMP standards are also conducted for diverse drug candidates.
Frontage Laboratories's top competitors include LabCorp, Charles River Laboratories and Cytel.
Frontage Laboratories offers Drug Discovery Services, Drug Development Services, and Laboratory Testing Services.
Yes, Frontage Laboratories is publicly traded on HKEX under the ticker symbol 1521.
Frontage Laboratories has made 7 acquisitions, including Acme Bioscience, BRI Biopharmaceutical Research, and BioTranex.
Frontage Laboratories has 2 investors. Key investors include Tigermed, and Baird Capital.
The ticker symbol of Frontage Laboratories is 1521 on HKEX.